JP2023535730A5 - - Google Patents
Info
- Publication number
- JP2023535730A5 JP2023535730A5 JP2023504555A JP2023504555A JP2023535730A5 JP 2023535730 A5 JP2023535730 A5 JP 2023535730A5 JP 2023504555 A JP2023504555 A JP 2023504555A JP 2023504555 A JP2023504555 A JP 2023504555A JP 2023535730 A5 JP2023535730 A5 JP 2023535730A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- cell
- formula
- permeable complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063056465P | 2020-07-24 | 2020-07-24 | |
| US63/056,465 | 2020-07-24 | ||
| PCT/US2021/043213 WO2022020810A1 (en) | 2020-07-24 | 2021-07-26 | A three component vaccine for covid-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535730A JP2023535730A (ja) | 2023-08-21 |
| JP2023535730A5 true JP2023535730A5 (https=) | 2024-05-27 |
Family
ID=79728449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504555A Pending JP2023535730A (ja) | 2020-07-24 | 2021-07-26 | Ｃｏｖｉｄ－１９の３成分ワクチン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240148858A1 (https=) |
| EP (1) | EP4185331A4 (https=) |
| JP (1) | JP2023535730A (https=) |
| CN (1) | CN116724118A (https=) |
| AU (1) | AU2021310952A1 (https=) |
| CA (1) | CA3189834A1 (https=) |
| WO (1) | WO2022020810A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250177559A1 (en) * | 2022-03-09 | 2025-06-05 | The Board Of Trustees Of The Leland Stanford Junior University | Branched lipid charge-altering releasable transporters for nucleic acid delivery |
| EP4493197A4 (en) * | 2022-03-17 | 2026-03-18 | Univ Leland Stanford Junior | COMPOSITIONS AND METHODS FOR ENHANCED PROTEIN TRANSLATION FROM RECOMBED CIRCULAR RNA |
| US20260014246A1 (en) * | 2022-07-11 | 2026-01-15 | The Uab Research Foundation | Treatment methods for viral infections |
| EP4630447A2 (en) * | 2022-12-09 | 2025-10-15 | Abwiz Bio, Inc. | Antibodies or fragments thereof for sars-cov-2 and variants thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999052549A1 (en) * | 1998-04-09 | 1999-10-21 | Smithkline Beecham Biologicals S.A. | Adjuvant compositions |
| KR20180014009A (ko) * | 2015-05-29 | 2018-02-07 | 머크 샤프 앤드 돔 코포레이션 | 암을 치료하기 위한 pd-1 길항제 및 cpg-c 유형 올리고뉴클레오티드의 조합 |
| CN115252807A (zh) * | 2016-07-27 | 2022-11-01 | 利兰斯坦福初级大学董事会 | 用于核酸递送的解体型细胞穿透性复合物 |
| KR20210125979A (ko) * | 2018-11-09 | 2021-10-19 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 핵산 전달을 위한 혼성 희생 세포-침투 복합체 |
| US11931416B2 (en) * | 2019-02-01 | 2024-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | Immolative cell-penetrating complexes for nucleic acid delivery to the lung |
| CN111217918B (zh) * | 2020-03-04 | 2020-11-10 | 中山大学 | 一种基于2,4-二氧四氢喋啶合酶的新型冠状病毒s蛋白双区域亚单位纳米疫苗 |
-
2021
- 2021-07-26 EP EP21845716.6A patent/EP4185331A4/en not_active Withdrawn
- 2021-07-26 AU AU2021310952A patent/AU2021310952A1/en not_active Abandoned
- 2021-07-26 CA CA3189834A patent/CA3189834A1/en active Pending
- 2021-07-26 JP JP2023504555A patent/JP2023535730A/ja active Pending
- 2021-07-26 CN CN202180064754.1A patent/CN116724118A/zh active Pending
- 2021-07-26 WO PCT/US2021/043213 patent/WO2022020810A1/en not_active Ceased
- 2021-07-26 US US18/006,264 patent/US20240148858A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023535730A5 (https=) | ||
| JP3273135B2 (ja) | 新規ペプチド核酸 | |
| JP7763907B2 (ja) | Ｂ型肝炎ウイルス感染のためのＲＮＡｉ薬 | |
| JP4589851B2 (ja) | 抗ウイルス性デンドリマー | |
| JP2024150603A (ja) | Ｂ型肝炎ウイルス感染のためのＲＮＡｉ薬 | |
| JP2006512927A5 (https=) | ||
| JP2003535146A5 (https=) | ||
| CN107531736B (zh) | 脂质a模拟物、其制备方法和用途 | |
| AU2006235284A1 (en) | Methods for treating infectious disease exacerbated asthma | |
| CN111527207A (zh) | GalNAc衍生物 | |
| CA2499036A1 (en) | 1,3,5-triazines for treatment of viral diseases | |
| AU2013262415B2 (en) | Oligonucleotide chelate complex methods | |
| WO2005014038A1 (ja) | 粘膜免疫誘導アジュバントを含む新規ワクチン | |
| TWI298328B (en) | Polyamide nucleic acid derivatives, and agents and process for preparing them | |
| JP2022526267A5 (https=) | ||
| JP2004501211A5 (https=) | ||
| DK1406667T3 (da) | Fremgangsmåder til at öge oligonukleotiders in vivo-effektivitet og hæmme inflammation hos pattedyr | |
| JP2002501722A5 (https=) | ||
| CN103168035A (zh) | 4-异丙基苯基山梨醇化合物的晶型及其制备方法 | |
| JP2004526737A5 (https=) | ||
| JP5428017B2 (ja) | ワクチン剤 | |
| US20210220454A1 (en) | Design of immunostimulatory protein-core spherical nucleic acids | |
| JP2001131074A (ja) | シアル酸誘導体を有効成分として含む医薬 | |
| JP2002531573A (ja) | グリセリルヌクレオチド、それらの製造法および使用 | |
| JP2025536115A (ja) | 膜貫通送達系およびその使用 |